Given the CV benefit noted in the CVOTs, GLP-1RAs and SGLT-2is are given preference in T2DM guidelines. While guidelines do not report potential gender difference, those differences exist. On restricting the CVOTs results to women with increased CV risk or established ASCVD, GLP-1RAs significantly reduced MACE while SGLT-2is resulted in a non-significant reduction.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pcd.2022.03.012 | DOI Listing |
Publication Analysis
Top Keywords
cardiovascular benefits
4
benefits glp-1ra
4
glp-1ra sglt-2i
4
sglt-2i women
4
women type
4
type diabetes
4
diabetes benefit
4
benefit cvots
4
cvots glp-1ras
4
glp-1ras sglt-2is
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!